PURPOSE: This study examines the anti-cancer effect of carnosol in human prostate cancer PC3 cells and its role in modulating multiple signaling pathways associated with carcinogenesis. METHODS: PC3 cells were treated with carnosol and were evaluated using a flow cytometry, a protein array and Western blot analysis to identify signaling pathways targeted by carnosol. RESULTS: Using an MTT assay we found that carnosol (10-70 microM) decreases cell viability in a time and dose-dependent manner. Further analysis using flow cytometry as well as biochemical analysis identified G2-phase cell cycle arrest. To establish a more precise mechanism, we performed a protein array that evaluated 638 proteins involved in cell signaling pathways. The protein array identified 5'-AMP-activated protein kinase (AMPK), a serine/threonine protein kinase involved in the regulation of cellular energy balance as a potential target. Further downstream effects consistent with cancer inhibition included the modulation of the mTOR/HSP70S6k/4E-BP1 pathway. Additionally, we found that carnosol targeted the PI3K/Akt pathway in a dose dependent manner. CONCLUSIONS: These results suggest that carnosol targets multiple signaling pathways that include the AMPK pathway. The ability of carnosol to inhibit prostate cancer in vitro suggests carnosol may be a novel agent for the management of PCa.
PURPOSE: This study examines the anti-cancer effect of carnosol in humanprostate cancer PC3 cells and its role in modulating multiple signaling pathways associated with carcinogenesis. METHODS: PC3 cells were treated with carnosol and were evaluated using a flow cytometry, a protein array and Western blot analysis to identify signaling pathways targeted by carnosol. RESULTS: Using an MTT assay we found that carnosol (10-70 microM) decreases cell viability in a time and dose-dependent manner. Further analysis using flow cytometry as well as biochemical analysis identified G2-phase cell cycle arrest. To establish a more precise mechanism, we performed a protein array that evaluated 638 proteins involved in cell signaling pathways. The protein array identified 5'-AMP-activated protein kinase (AMPK), a serine/threonine protein kinase involved in the regulation of cellular energy balance as a potential target. Further downstream effects consistent with cancer inhibition included the modulation of the mTOR/HSP70S6k/4E-BP1 pathway. Additionally, we found that carnosol targeted the PI3K/Akt pathway in a dose dependent manner. CONCLUSIONS: These results suggest that carnosol targets multiple signaling pathways that include the AMPK pathway. The ability of carnosol to inhibit prostate cancer in vitro suggests carnosol may be a novel agent for the management of PCa.
Authors: B E Kemp; D Stapleton; D J Campbell; Z-P Chen; S Murthy; M Walter; A Gupta; J J Adams; F Katsis; B van Denderen; I G Jennings; T Iseli; B J Michell; L A Witters Journal: Biochem Soc Trans Date: 2003-02 Impact factor: 5.407
Authors: M T Huang; C T Ho; Z Y Wang; T Ferraro; Y R Lou; K Stauber; W Ma; C Georgiadis; J D Laskin; A H Conney Journal: Cancer Res Date: 1994-02-01 Impact factor: 12.701
Authors: Jeremy J Johnson; Deeba N Syed; Yewseok Suh; Chenelle R Heren; Mohammad Saleem; Imtiaz A Siddiqui; Hasan Mukhtar Journal: Cancer Prev Res (Phila) Date: 2010-08-24
Authors: Jeremy J Johnson; Sakina M Petiwala; Deeba N Syed; John T Rasmussen; Vaqar M Adhami; Imtiaz A Siddiqui; Amanda M Kohl; Hasan Mukhtar Journal: Carcinogenesis Date: 2011-12-09 Impact factor: 4.944
Authors: Alberto Valdés; Virginia García-Cañas; Konstantin A Artemenko; Carolina Simó; Jonas Bergquist; Alejandro Cifuentes Journal: Mol Cell Proteomics Date: 2016-11-10 Impact factor: 5.911
Authors: Julia Bauer; Susanne Kuehnl; Judith M Rollinger; Olga Scherer; Hinnak Northoff; Hermann Stuppner; Oliver Werz; Andreas Koeberle Journal: J Pharmacol Exp Ther Date: 2012-04-16 Impact factor: 4.030